The Latest Headlines at American Banking and Market News
Capstone Capital Wealth Advisors Purchases Shares of 1,575 Microsoft Co. (NASDAQ:MSFT)
Capstone Capital Wealth Advisors acquired a new stake in Microsoft Co. (NASDAQ:MSFT – Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired... More of this article »
Microsoft Co. (NASDAQ:MSFT) Stake Lifted by Carderock Capital Management Inc.
Carderock Capital Management Inc. grew its position in Microsoft Co. (NASDAQ:MSFT – Free Report) by 3.4% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned... More of this article »
Arcadia Wealth Management LLC Increases Position in Microsoft Co. (NASDAQ:MSFT)
Arcadia Wealth Management LLC boosted its position in Microsoft Co. (NASDAQ:MSFT – Free Report) by 2.6% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 1,474 shares of the software giant’s... More of this article »
Microsoft Co. (NASDAQ:MSFT) Shares Sold by Baker Ellis Asset Management LLC
Baker Ellis Asset Management LLC cut its holdings in Microsoft Co. (NASDAQ:MSFT – Free Report) by 0.7% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 53,085 shares... More of this article »
Microsoft Co. (NASDAQ:MSFT) Stake Lowered by Farmers & Merchants Investments Inc.
Farmers & Merchants Investments Inc. cut its holdings in Microsoft Co. (NASDAQ:MSFT – Free Report) by 0.1% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission... More of this article »
BML Capital Management LLC Invests $686,000 in Aclaris Therapeutics, Inc. (NASDAQ:ACRS)
BML Capital Management LLC bought a new position in shares of Aclaris Therapeutics, Inc. (NASDAQ:ACRS – Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission... More of this article »
BML Capital Management LLC Acquires 26,000 Shares of Lisata Therapeutics, Inc. (NASDAQ:LSTA)
BML Capital Management LLC raised its holdings in Lisata Therapeutics, Inc. (NASDAQ:LSTA – Free Report) by 10.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC).... More of this article »
Milestone Pharmaceuticals Inc. (NASDAQ:MIST) Shares Purchased by BML Capital Management LLC
BML Capital Management LLC increased its stake in shares of Milestone Pharmaceuticals Inc. (NASDAQ:MIST – Free Report) by 62.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission... More of this article »
BML Capital Management LLC Purchases 30,000 Shares of Verrica Pharmaceuticals Inc. (NASDAQ:VRCA)
BML Capital Management LLC increased its position in Verrica Pharmaceuticals Inc. (NASDAQ:VRCA – Free Report) by 20.0% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange... More of this article »
BML Capital Management LLC Makes New Investment in Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM)
BML Capital Management LLC bought a new position in Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM – Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund... More of this article »
BML Capital Management LLC Makes New $2.43 Million Investment in Connect Biopharma Holdings Limited (NASDAQ:CNTB)
BML Capital Management LLC acquired a new position in Connect Biopharma Holdings Limited (NASDAQ:CNTB – Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange... More of this article »
BML Capital Management LLC Purchases 50,000 Shares of Vistagen Therapeutics, Inc. (NASDAQ:VTGN)
BML Capital Management LLC grew its position in shares of Vistagen Therapeutics, Inc. (NASDAQ:VTGN – Free Report) by 50.0% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission... More of this article »
1,029,478 Shares in Design Therapeutics, Inc. (NASDAQ:DSGN) Acquired by BML Capital Management LLC
BML Capital Management LLC bought a new position in shares of Design Therapeutics, Inc. (NASDAQ:DSGN – Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange... More of this article »